The US Food and Drug Administration has granted an emergency use authorization (EUA) to the Yale School of Public Health for its SalivaDirect test for the rapid detection of the SARS-CoV-2 virus in saliva samples.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?